Cargando…
Study of FGF21 Levels in Transgender People and its Association with Metabolic Parameters
BACKGROUND: Fibroblast growth factor (FGF21) is a metabolic regulator whose role in humans is unidentified. FGF21 has generated a lot of potential of becoming a therapeutic agent for the management of type 2 diabetes mellitus and dyslipidaemia. The role of FGF21 in gender dysphoria individuals has n...
Autores principales: | Kumbar, Lohit, Kiran, Baratam Hari, Dharmalingam, Mala, Kalra, Pramila |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10586550/ https://www.ncbi.nlm.nih.gov/pubmed/37867987 http://dx.doi.org/10.4103/ijem.ijem_307_22 |
Ejemplares similares
-
Abstract 65: Effects of gender affirming hormone therapy on metabolic health and body composition in gender dysphoria
por: Kiran, Baratam Hari, et al.
Publicado: (2022) -
Serum Fibroblast Growth Factor 21 Levels in Patients with Hyperthyroidism and its Association with Body Fat Percentage
por: Bande, Aashish Reddy, et al.
Publicado: (2019) -
Perioperative Glycemic Control in Patients who Underwent Cardiac Transplantation and Effect on the Outcome at Discharge in a Tertiary Care Centre
por: Kumbar, Lohit, et al.
Publicado: (2020) -
Vitamin D deficiency presenting like hypophosphatemic osteomalacia
por: Mittal, Rajneesh, et al.
Publicado: (2012) -
Prepregnancy Hypothyroidism versus Gestational Hypothyroidism: A Comparative Study
por: Kaduskar, Prashant Ulhas, et al.
Publicado: (2017)